GetPortalImpactFactorByIdResp(projectId=1, id=5d7e3078, cover=null, fullname=immunology today, abbr=IMMUNOL TODAY, pyear=暂无数据, frequence=null, articleNumbers=0, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2018年中国人文章占该期刊总数量暂无数据 (2017年为暂无数据), issn=0167-5699, greenSci=https://www.greensci.net/search?kw=0167-5699, scijournal=https://www.scijournal.org/impact-factor-of-IMMUNOL-TODAY.shtml, medsciHotlightString=null, medsciHotlightRealtime=0.456, medsciHotlight=0.451, medsciHotlight5year=0.619705, citescore=0.0, hIndex=0, impactFactor=null, orgnization=Elsevier BV, orgnizationUrl=http://www.elsevier.com, country=Netherlands, countryCn=荷兰, isOa=null, isOaString=不清楚, sciScie=null, bigclassCas=null, smallclassCas=, website=null, websiteHits=1658, guideForAuthor=null, guideForAuthorHits=1, submitWebsite=, submitWebsiteHits=1, content=Immunology Letters provides a vehicle for the speedy publication of full-length and short articles, Rapid Notes, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings. Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion. Within a reference section, new mRNA sequences with unknown function, expressed sequence tags with tissue distribution and novel monoclonal antibody descriptions are considered for publication., totalCites=null, brief=IMMUNOL TODAY杂志暂不明确行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=5d7e3078'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2012, citescore=0.0), GetImpactFactorCiteScoreListResponse(year=2013, citescore=0.0), GetImpactFactorCiteScoreListResponse(year=2014, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2019, medsciHotlight=0.844), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=0.442), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=0.458), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=0.611), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=0.456)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0167-5699[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=immunology today[ta], article_number=0, article_number_cn=null, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)